Cargando…
Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis
BACKGROUND: Uncertainty exists regarding the clinical relevance of programmed cell death ligand 1 (PD-L1) expression in breast cancer. METHODS: A systematic review was performed in accordance with PRISMA guidelines. Observational studies that compared high versus low expression of PD-L1 on breast ca...
Autores principales: | Davey, M G, Ryan, É J, Davey, M S, Lowery, A J, Miller, N, Kerin, M J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364926/ https://www.ncbi.nlm.nih.gov/pubmed/33963374 http://dx.doi.org/10.1093/bjs/znab103 |
Ejemplares similares
-
Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis
por: Davey, Matthew G., et al.
Publicado: (2022) -
Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis
por: Davey, M G, et al.
Publicado: (2021) -
Optimal primary wound closure methods after thyroid and parathyroid surgery: network meta-analysis of randomized clinical trials
por: Davey, Matthew G, et al.
Publicado: (2023) -
Overview of MicroRNA Expression in Predicting Response to Neoadjuvant
Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A
Systematic Review
por: Davey, Matthew G, et al.
Publicado: (2022) -
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
por: Kim, Hye Min, et al.
Publicado: (2017)